Non-acute myocardial infarction-associated cardiogenic shock in Hispanic patients: An analysis from the National Inpatient Sample Database.
| Autor: | Javed N; BronxCare Health System, Bronx, NY, USA., Jadhav P; BronxCare Health System, Bronx, NY, USA.; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chilimuri S; BronxCare Health System, Bronx, NY, USA.; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Contreras J; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Tamis-Holland J; Cleveland Clinic Foundation, Cleveland, OH, USA., Bella JN; BronxCare Health System, Bronx, NY, USA.; Icahn School of Medicine at Mount Sinai, New York, NY, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | American heart journal plus : cardiology research and practice [Am Heart J Plus] 2024 Sep 21; Vol. 46, pp. 100462. Date of Electronic Publication: 2024 Sep 21 (Print Publication: 2024). |
| DOI: | 10.1016/j.ahjo.2024.100462 |
| Abstrakt: | Background: Current knowledge about non-acute myocardial infarction-associated cardiogenic shock (nAMI-CS) by ethnicity is limited. This study compares clinical features and outcomes of nAMI-CS in Hispanic versus non-Hispanic patients in the U.S. Methods: Hospitalizations with nAMI-CS from 2018 to 2020 were identified using the National Inpatient Sample (NIS) database. Patients were classified by ethnicity (Hispanic vs. non-Hispanic). Statistical analysis, including Chi-square and t -tests, was conducted using STATA version 18. Results: Out of 8607 nAMI-CS hospitalizations, 832 (9.6 %) were Hispanic. Hispanic patients were younger (62.3 ± 15.2 vs. 66.2 ± 15.3 years) and had higher incidences of smoking (2.4 % vs. 2.1 %), coronary artery disease (45.4 % vs. 44.1 %), myocardial infarction (2.9 % vs. 1.9 %), heart failure (10.1 % vs. 9.2 %), and diabetes mellitus (18.9 % vs. 18.1 %). They had lower incidences of hypertension (32.9 % vs. 34.3 %), valve disease (1.9 % vs. 2.1 %), and cerebrovascular disease (6.5 % vs. 8.5 %, all p < 0.005). Hispanic patients had slightly higher in-hospital mortality rates (18.6 % vs. 17 %, p < 0.001), with an adjusted odds ratio (aOR) of 1.20 (95 % CI: 1.01-1.50, p = 0.01). Their hospital stays were longer (17.7 ± 1.87 vs. 13.2 ± 0.31 days, p = 0.03) and costlier ($409,280 ± 591,582 vs. $291,298 ± 461,920, p = 0.03). Conclusion: Hispanic nAMI-CS patients are younger, have more co-morbid conditions, longer hospital stays, higher costs, and higher in-hospital mortality rates than non-Hispanic patients. Further research is needed to understand the mechanisms behind these disparities. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2024 The Author(s).) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|